Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
16 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Legend Biotech Belgium from Gent, company number BE0769992730, closed financial year 2025 with a result of € 14.2 million after tax. For that financial year Legend Biotech Belgium recorded revenue of € 285.9 million and equity of € 62.9 million. Compared with financial year 2024, the result moved from € 2.2 million to € 14.2 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ 62.9 million
▲ 29% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 14.2 million
▲ € 12.1 million vs 2024
Profit after tax over the fiscal year.
€ 41.9 million
▲ 32% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 15.9 million.
People and assets in 2025
846.9
▲ 416.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 86.3 million
▲ 95% vs 2024
€ 101,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 47,705
▼ 63% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 53.4 million
▲ € 48.6 million vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 108 days on average.
€ 22.1 million
▲ 99% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | € 39,137,262 | € 285,921,208 | ▲ € 246.8 million |
| Gross margin | € -3,163,433 | € 29,151,537 | - | - | |
| Profit after taxes | € -9,153,850 | € 9,095,754 | € 2,156,432 | € 14,218,599 | ▲ € 12.1 million |
| Equity | € 37,402,849 | € 46,498,603 | € 48,655,036 | € 62,873,635 | ▲ 29% |
| Total debts | € 8,641,659 | € 10,873,966 | € 18,371,107 | € 79,490,284 | ▲ € 61.1 million |
| Cash | € 44,957,622 | € 13,783,203 | € 31,684,534 | € 41,873,965 | ▲ 32% |
| Retained profit | € -9,597,151 | € -501,397 | € 1,655,036 | € 15,873,635 | ▲ € 14.2 million |
| Bank debt | € 6,000,000 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 46,044,508 | € 57,372,569 | € 67,026,142 | € 142,363,919 | ▲ 112% |
| Employees (FTE) | 37.6 | 165.1 | 430.4 | 846.9 | ▲ 416.5 |
Key figures of Legend Biotech Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Legend Biotech Belgium?
What happened at Legend Biotech Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 14.2 million (▲ € 12.1 million vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- New establishment in Gent. KBO
- Fangliang Zhang became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
- Ying Huang became a director. NBB
In short
From € 9.2 million loss in 2022 to € 14.2 million profit in 2025.
Paid € 6.4 million in corporate taxes since 2022.
Best year ever: 2025, with € 14.2 million profit.
On average € 176,600 of value added per employee in 2023.
A new publication or filing at Legend Biotech Belgium? We notify you, reason included.
Follow Legend Biotech BelgiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Legend Biotech Belgium are Fangliang Zhang and Ying Huang. The shares are held by Legend Biotech Ireland Limited (100%).
Directors
According to the 2025 annual accounts
Fangliang Zhang
Director
since 2022
Ying Huang
Director
since 2021
Shareholders
Legend Biotech Ireland Limited
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 122
9052 Gent
Suzanne Tassierstraat 8
9052 Gent
Active since 12 June 2023
Technologiepark-Zwijnaarde 73 Obelisk
9052 Gent
Active since 25 May 2023
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
All companies at this address →EYKON
€ 50 million revenue · 2026
1T3XT GROEP
AVGI
€ 676,960 gross margin · 2025
Apryse
Sentea
€ 913,263 revenue · 2025
+11 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0769.992.730
- VAT number
- BE 0769.992.730
- Registered office
- Technologiepark-Zwijnaarde 122, 9052 Gent
- Names & denominations
- Legend Biotech Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 June 2021
- Peppol
- Active · Active since 21 Nov 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Activiteiten van medische beeldvorming en medische laboratoria
Overige zakelijke dienstverlening, neg
Activiteiten van medische laboratoria